Thrombotic Events in MASLD Cirrhosis Versus Cirrhosis of Other

Authors

Prince A. Ameyaw, Internal Medicine, Bridgeport Hospital/Yale New Haven Health, Bridgeport, USA.
Sarpong Boateng, Internal Medicine, Bridgeport Hospital/Yale New Haven Health, Bridgeport, USA.
Rofinna Johnkennedy MD, MPH, Yale New Haven Health/Bridgeport Hospital
Karthik Mathialagan, Department of Medicine, Yale-New Haven Health-Bridgeport Hospital, Bridgeport, CT.
Basile Njei, Department of Medicine, Section of Digestive Diseases, Yale University School of Medicine, West Haven, CT, USA.

Document Type

Conference Proceeding

Abstract

The complex physiologic changes of cirrhosis increase the risks of thrombotic and hemorrhagic complications. Thrombosis in cirrhosis increases in-patient and 90-day mortality. MASLD increases thrombotic risks independent of cirrhosis. We investigate the impact of cirrhosis etiology on risk

Publication Date

Fall 2024

Recommended Citation

Ameyaw, Prince A.; Boateng, Sarpong; Johnkennedy, Rofinna MD, MPH; Mathialagan, Karthik; and Njei, Basile, "Thrombotic Events in MASLD Cirrhosis Versus Cirrhosis of Other" (2024). Posters. 31.
https://scholar.bridgeporthospital.org/poster_presentations/31